• Earlier this week, Morgan Stanley downgraded Hess Midstream to Underweight from Equal-weight, citing concerns around valuation and limited visibility into long-term growth and sponsor strategy.
• This shift in analyst stance puts a spotlight on how much confidence investors can place in Hess Midstream’s long-range plans and capital allocation framework.
• We’ll now examine how Morgan Stanley’s concerns about long-term growth visibility may influence Hess Midstream’s existing investment narrative.

Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.

Hess Midstream Investment Narrative Recap

To own Hess Midstream, you need to believe in the durability of its fee-based contracts with Hess/Chevron and ongoing Bakken throughput supporting steady cash flows and distributions. Morgan Stanley’s downgrade raises questions around how long that growth can continue, but it does not appear to materially change the near term focus on executing 2026 volume and earnings guidance. The bigger risk today remains Hess Midstream’s dependence on Chevron’s drilling and capital allocation plans in the Bakken.

The most relevant recent development is Hess Midstream’s reaffirmation of its full year 2026 net income guidance of US$650 million to US$700 million, alongside detailed throughput targets across gas, oil and water systems. This outlook provides a concrete yardstick against which investors can judge whether Morgan Stanley’s concerns about limited long term growth visibility show up in actual volumes and earnings, or whether the current Bakken program and contract structure keep Hess Midstream’s near term catalysts intact.

Yet investors should be aware that if Chevron shifts its Bakken strategy or capital spending, Hess Midstream’s...

Hess Midstream's narrative projects $1.8 billion revenue and $554.1 million earnings by 2029.

Uncover how Hess Midstream's forecasts yield a $36.83 fair value, a 5% downside to its current price.

Exploring Other Perspectives

Four fair value estimates from the Simply Wall St Community span roughly US$18 to US$95 per share, showing just how far apart views can be. Against that wide range, Hess Midstream’s reliance on sustained Bakken production growth highlights why you may want to consider several different opinions before deciding how its future performance could unfold.

Explore 4 other fair value estimates on Hess Midstream - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Hess Midstream research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Hess Midstream research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Hess Midstream's overall financial health at a glance.

Want Some Alternatives?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• Find 48 companies with promising cash flow potential yet trading below their fair value.
• Capitalize on the AI infrastructure supercycle with our selection of the 48 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Uncover the next big thing with 25 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.